Moise W. Anglade

Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation.

J. Kluger, C. Coleman, Soyon Lee, 2012, The American journal of cardiology.

Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.

J. Kluger, D. Sobieraj, C. Coleman, 2012, The American journal of cardiology.

A Meta-Analysis Evaluating the Impact of Chitosan on Serum Lipids in Hypercholesterolemic Patients

C. White, W. Baker, C. Coleman, 2009, Annals of Nutrition and Metabolism.

Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis.

C. White, Erica L. Baker, J. Kluger, 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study

C. Michael White, J. Kluger, C. Coleman, 2007, Current medical research and opinion.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Diane M. Miller, Natalia E. Shilkina, M. C. Cantero, 2018, Lancet.

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin

J. Kluger, C. Coleman, Soyon Lee, 2012, Circulation. Cardiovascular quality and outcomes.

IntravenousCorticosteroid Use Is Associated With Reduced Early Recurrence of Atrial Fibrillation Immediately Following Radiofrequency Catheter Ablation.

J. Kluger, C. Coleman, N. Sood, 2011, Journal of atrial fibrillation.

Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis.

J. Kluger, W. Baker, C. Coleman, 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.

J. Kluger, D. Sobieraj, C. Coleman, 2012, The American journal of cardiology.